Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Bone morphogenetic protein receptor type-1A [198-525] | ||
Ligand | BDBM451825 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ADPGlo Assay | ||
IC50 | 920±n/a nM | ||
Citation | Arista, L; Babu, S; Bian, J; Cui, K; Dillon, MP; Lattmann, R; Li, J; Liao, L; Lizos, D; Ramos, R; Stiefl, NJ; Ullrich, T; Usselmann, P; Wang, X; Waykole, LM; Weiler, S; Zhang, Y; Zhou, Y; Zhu, T Aminopyridine derivatives and their use as selective ALK-2 inhibitors US Patent US10710980 Publication Date 7/14/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
Bone morphogenetic protein receptor type-1A [198-525] | |||
Name: | Bone morphogenetic protein receptor type-1A [198-525] | ||
Synonyms: | ACVRLK3 | ALK3 | Activin receptor-like kinase 3 (ALK3) (aa 198-525) | Activin receptor-like kinase 3 (ALK3)(198-525) | BMPR1A | BMR1A_HUMAN | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 37140.17 | ||
Organism: | Homo sapiens (Human) | ||
Description: | aa 198-525 | ||
Residue: | 328 | ||
Sequence: |
| ||
BDBM451825 | |||
n/a | |||
Name | BDBM451825 | ||
Synonyms: | US10710980, Example 54 | US10947218, Example 54 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H30N4O2 | ||
Mol. Mass. | 430.542 | ||
SMILES | Nc1ncc(cc1C(=O)N[C@H]1CC[C@H](O)CC1)-c1ccc(cc1)[C@@]12C[C@@H]1CN(CC#C)C2 |r,wU:23.25,10.10,wD:13.14,25.27,(-4.69,4.29,;-3.36,3.52,;-2.02,4.29,;-.69,3.52,;-.69,1.98,;-2.02,1.21,;-3.36,1.98,;-4.69,1.21,;-6.03,1.98,;-4.69,-.33,;-6.03,-1.1,;-6.16,-2.64,;-7.56,-3.29,;-8.82,-2.4,;-10.04,-3.01,;-8.68,-.87,;-7.29,-.22,;.64,1.21,;.64,-.33,;1.98,-1.1,;3.31,-.33,;3.31,1.21,;1.98,1.98,;4.64,-1.1,;4.8,.43,;6.05,-.48,;7.08,-1.62,;6.31,-2.95,;7.08,-4.29,;8.51,-4.29,;10.04,-4.29,;4.8,-2.63,)| | ||
Structure |